Absea Biotechnology
Beijing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A Chinese biotech developing novel therapeutic antibodies and integrated diagnostic tools.
OncologyAutoimmune Diseases
Technology Platform
An integrated antibody discovery platform utilizing phage display and hybridoma technologies for generating high-specificity therapeutic and diagnostic antibodies.
Opportunities
Significant opportunity in China's growing biopharma market and in developing companion diagnostics for targeted therapies.
Risk Factors
High risk of pipeline candidates failing in preclinical or clinical development, and intense competition in the antibody space.
Competitive Landscape
Operates in the highly competitive global antibody therapeutics market, competing with large pharma and numerous biotechs on target novelty and platform efficiency.